SCHEMBL17042811

SCHEMBL17042811

CC(C)C12CC3CC(c4ccc(O)c(-c5ccccc5)c4)(CC(c4ccc(O)c(-c5ccccc5)c4)(C3)C1)C2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.38
GAA P10253 2/20 0.38
MEN1 O00255 1/20 0.38
GFER P55789 1/20 0.38
KMT2A Q03164 1/20 0.38
CYP2D6 P10635 1/20 0.36
BACE1 P56817 2/20 0.36
ALDH1A1 P00352 3/20 0.35
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
PELI1 Q96FA3 1/20 0.32
HPGD P15428 1/20 0.32
BCL2L1 Q07817 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CCR2 P41597 1/20 0.32
HSD17B1 P14061 1/20 0.32
HSD17B2 P37059 1/20 0.32
RXRA P19793 1/20 0.31
NR4A2 P43354 1/20 0.31
GRIN2D O15399 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6763594 0.88 MEN1 (0.46) POLBGAAMEN1GFERKMT2A
SCHEMBL30375298 0.88 MEN1 (0.46) POLBGAAMEN1GFERKMT2A
SCHEMBL17042212 0.86 BACE1 (0.41) CYP2D6BACE1ALDH1A1MAOAMAOB
SCHEMBL17042615 0.84 PTPN11 (0.40) POLBGAAMEN1GFERKMT2A
SCHEMBL17042842 0.81 CYP2D6 (0.37) CYP2D6BACE1ALDH1A1MAOAMAOB
SCHEMBL17042483 0.81 GRIN2D (0.42) POLBGAAMEN1GFERKMT2A
SCHEMBL17042697 0.81 ESR1 (0.42) POLBGAAMEN1GFERKMT2A
SCHEMBL17042487 0.81 MEN1 (0.38) POLBGAAMEN1GFERKMT2A
SCHEMBL17042864 0.81 GRIN2D (0.52) POLBGAAMEN1GFERKMT2A
SCHEMBL3974233 0.80 MEN1 (0.51) POLBGAAMEN1GFERKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025022769-A1 CYANATE ESTER COMPOUND AND METHOD FOR PRODUCING SAME, RESIN COMPOSITION, AND CURED PRODUCT 三菱瓦斯化学株式会社 2025-01-30 WO disclosed
WO-2025022768-A1 CYANATE ESTER COMPOUND AND METHOD FOR PRODUCING SAME, RESIN COMPOSITION, AND CURED PRODUCT 三菱瓦斯化学株式会社 2025-01-30 WO disclosed
EP-2913302-B1 CYANOGEN-HALIDE PRODUCTION METHOD, CYANATE ESTER COMPOUND AND PRODUCTION METHOD THEREFOR, AND RESIN COMPOSITION MITSUBISHI GAS CHEMICAL CO (JP) 2019-04-10 EP disclosed
US-9475761-B2 Method for producing cyanogen-halide, cyanate ester compound and method for producing the same, and resin composition MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2016-10-25 US disclosed
US-20150299110-A1 METHOD FOR PRODUCING CYANOGEN-HALIDE, CYANATE ESTER COMPOUND AND METHOD FOR PRODUCING THE SAME, AND RESIN COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2015-10-22 US disclosed
EP-2913302-A1 CYANOGEN-HALIDE PRODUCTION METHOD, CYANATE ESTER COMPOUND AND PRODUCTION METHOD THEREFOR, AND RESIN COMPOSITION Mitsubishi Gas Chemical Company, Inc. (JP) 2015-09-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150299110-A1 METHOD FOR PRODUCING CYANOGEN-HALIDE, CYANATE ESTER COMPOUND AND METHOD FOR PRODUCING THE SAME, AND RESIN COMPOSITION MB, CBR3, CRYAA POLB 896/4885GAA 1655/4885MEN1 296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.